Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 71Observational 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Carcinoma, Hepatocellular 2Lung Neoplasms 1

Interventions

Surveys and Questionnaires 13Blood Specimen Collection 13Specimen Handling 10Magnetic Resonance Spectroscopy 5Surgical Procedures, Operative 4Radiotherapy 4Observation 4Data Collection 4ribociclib 3darolutamide 3Watchful Waiting 3Standard of Care 3Patient Reported Outcome Measures 3Mental Status and Dementia Tests 3Interviews as Topic 3Immune Checkpoint Inhibitors 3Hepatectomy 3Breath Tests 3Biopsy 3trastuzumab deruxtecan 2palbociclib 2atezolizumab 2X-Rays 2Ultrasonography 2Tomography, X-Ray Computed 2Sulfonylurea Compounds 2Restraint, Physical 2Neoadjuvant Therapy 2Methods 2Mass Screening 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × atezolizumab × 30 days × Clear all
NCT07610551 2026-05-28

Efficacy and Safety of SIRT-Y90 in Combination With Atezo + Bev for Unresectable Hepatocellular Carcinoma

Air Force Military Medical University, China

Recruiting
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07284121 2026-05-26

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

Hoffmann-La Roche

Recruiting
700 enrolled
GastrointestinalThoracic

Carcinoma, Hepatocellular, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡